# Association of Immune-Related Adverse Events and the Efficacy of Anti–PD-(L)1 Monotherapy in Non–Small Cell Lung Cancer: Adjusting for Immortal-Time Bias

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/association-of-immune-related-adverse-events-and-the-efficacy-of-anti-pd-l-1/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ying Yu,Ning Chen,Sizhe Yu,Wanji Shen,Wanchen Zhai,Hui Li,Yun Fan |
| Citations | 19 |
| DOI | 10.4143/crt.2023.1118 |
| Fields | Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | http://www.e-crt.org/upload/pdf/crt-2023-1118.pdf |
| OpenAlex ID | https://openalex.org/W4390504662 |
| PMID | 38186241 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Ying Yu](https://scholariq.org/researchers/ying-yu/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.